SinoMab BioScience Limited (03681.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 1.15

From 52W high−47.18%

Volume299100.00

Market capHKD 1.54B

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataSep 18, 2026

Open

HKD 1.15

From 52W high

−47.18%

Volume

299100.00

Market cap

HKD 1.54B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−8.9x

P/E (TTM)

—

RSI (14)

47.1

MomentumView details →

1D Return

−2.17%

YTD Return

−16.04%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−8.9x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

3.6x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−50.29%

ROA (TTM)

−26.56%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

−100.00%

EPS YoY

+0.60%

FCF YoY

−62.28%

Revenue CAGR 3Y

−100.00%

EPS CAGR 3Y

+50.94%

EBITDA YoY

−31.04%

MomentumView details →

1D Return

−2.17%

YTD Return

−16.04%

1Y Return

−41.41%

RSI (14)

47.1

vs 50D SMA

−5.10%

vs 200D SMA

−20.99%

Capital & dividendView details →

Debt/Equity

0.74x

Current Ratio

1.35x

Quick Ratio

1.35x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−HKD 0.10

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

5.73M

Net Income (TTM)

−326.11M

Op. CF (TTM)

—

Next earningsMar 22, 2027 →

Latest newsMore news →

China Antibody-B announced that Liang Fang resigned as executive director and chief operating officer, effective August 18, 2026, to devote more time to personal affairs.33d ago

Similar companies

Kardigan, Inc.KARD Innoviva, Inc.INVA RAPT Therapeutics, Inc.RAPT Shandong Boan Biotechnology Co., Ltd.06955.HK Syndax Pharmaceuticals, Inc.SNDX Eton Pharmaceuticals, Inc.ETON Find similar companies →

Latest newsMore news →

China Antibody-B announced that Liang Fang resigned as executive director and chief operating officer, effective August 18, 2026, to devote more time to personal affairs.33d ago